Medicare plans to mail a blue notice, labeled CMS Product No. 11443, in late October or early November to people who get Extra Help with drug costs and whose Medicare Advantage plan is leaving the program. According to the agency’s page on the notice, a person who does nothing is reassigned to a Medicare drug plan for the coming year. The mailing window opens after the annual open enrollment period begins on October 15, so the notice lands in the middle of the choice it describes.
Who the blue notice is for
The audience is narrow. Medicare says the notice goes to people who get Extra Help, the program that lowers drug costs for people with limited income and resources, and whose current Medicare Advantage plan is leaving Medicare. It is not the general plan-exit letter, and the automatic reassignment it describes is an Extra Help feature rather than something every member of a leaving plan faces.
Extra Help has income and resource limits. Medicare’s drug costs page lists the 2026 limits for a single person at $23,940 in income and $18,090 in resources, and for a married couple at $32,460 in income and $36,100 in resources.
What the reassignment does
The notice tells the recipient that Medicare will assign a drug plan for the coming year unless the person joins a new Medicare Advantage plan or a Medicare drug plan on their own. Medicare’s page boils the advice down to three steps: keep the notice, compare plans to find one that meets the person’s needs, and change plans in early December if that is the choice.
The page carries no dollar figures and no specific deadline date, and it names no insurer, plan or county. The date that ends the window, December 7, comes from a separate Medicare page covered below.
For a household on Extra Help, the practical question is whether the drug plan Medicare picks covers the medicines already being taken. A person who receives the blue notice can accept the reassignment or sign up for a plan of their own choosing by December 7, and the step that matters most in either case is listing every prescription and checking each one against the plan Medicare would assign and against any plan the person would pick instead.
A blue notice that arrives in late October or early November leaves roughly five to six weeks before December 7 to replace the plan Medicare would assign. The 2027 Medicare Open Enrollment Decision Kit includes a prescription-by-plan comparison for checking each drug against the plans on the table.
Open the Decision Kit’s prescription-by-plan comparison for the blue notice →
The calendar around the mailing
Medicare.gov says the annual open enrollment period runs October 15 to December 7, and that coverage chosen in that window starts January 1 of the next year as long as the plan has the request by December 7. The notice’s own advice, to change plans in early December, sits inside that window. The mailing, set for late October or early November, leaves about five to six weeks before the December 7 cutoff.
Open enrollment opens October 15. The blue notice, by Medicare’s own timing, comes after that date, which means the window is already running by the time the envelope reaches a mailbox.
What Extra Help changes about the drug bill
Medicare’s drug costs page lists Extra Help copayments for 2027 of up to $5.80 for each generic drug and up to $14.40 for each brand-name drug. It also says that once total drug costs reach $2,400, the person pays $0 per covered drug. Those amounts come from the program, and the plan chosen still decides which drugs are on its list.
The wider Part D rules are published on the drug coverage costs page. Medicare lists the Part D out-of-pocket cap at $2,100 in 2026 and $2,400 in 2027, and says no Medicare drug plan may have a deductible above $615 in 2026 or $700 in 2027. The same page warns that the Medicare Prescription Payment Plan, which spreads out-of-pocket drug costs across the calendar year, “doesn’t save you money or lower your drug costs.”
Help that sits outside the drug plan
Separate from Extra Help, the four Medicare Savings Programs have their own 2026 limits. For an individual, Medicare lists the Qualified Medicare Beneficiary program at $1,350 a month in income and $9,950 in resources, the Specified Low-Income Medicare Beneficiary program at $1,616 a month, and the Qualifying Individual program at $1,816 a month, with the same $9,950 resource limit. The Qualified Medicare Beneficiary program covers Part B premiums, deductibles, coinsurance and copayments, and Part A premiums for people who do not get Part A premium-free.
The blue notice does not mention any of these programs. They are a separate check for a household reviewing its costs while the drug plan question is open.
Comparing replacement drug plans before December 7
The free place to start is Medicare.gov’s page on joining a plan, which sets the October 15 to December 7 window and explains how a request reaches a plan. Medicare also tells recipients of the blue notice to keep it, so the letter should stay with the plan papers.
Before comparing, gather the full list of prescriptions with strengths and the pharmacy used, plus proof of Extra Help status. Each candidate plan, including the one Medicare would assign, can then be checked drug by drug, with the Extra Help copays of up to $5.80 for generics and $14.40 for brand-name drugs in 2027 as the cost yardstick.
The one-line guidance on Medicare’s notice page is the whole instruction: keep the notice, compare plans, and change in early December if that is the choice.
Reassigned to a drug plan nobody compared
Doing nothing after the blue notice leaves the plan Medicare picks in place for the coming year, whether or not it covers the medicines on the shelf. The 2027 Medicare Open Enrollment Decision Kit lays out the Open Enrollment calendar and a provider call script alongside its prescription-by-plan comparison, so each drug and each doctor gets checked against a plan before December 7.
Check every drug and doctor before the December 7 cutoff with the Decision Kit →
This article was produced with AI assistance and edited for accuracy against the sources linked above.
